388 related articles for article (PubMed ID: 28767209)
1. Preventive Effects of Suvorexant on Delirium: A Randomized Placebo-Controlled Trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Ito S; Kurata A; Murakami K; Sugita M; Usui C; Nakamura H;
J Clin Psychiatry; 2017; 78(8):e970-e979. PubMed ID: 28767209
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
[TBL] [Abstract][Full Text] [Related]
3. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
[TBL] [Abstract][Full Text] [Related]
4. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
Adams AD; Pepin MJ; Brown JN
J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
[TBL] [Abstract][Full Text] [Related]
5. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.
Herring WJ; Connor KM; Ivgy-May N; Snyder E; Liu K; Snavely DB; Krystal AD; Walsh JK; Benca RM; Rosenberg R; Sangal RB; Budd K; Hutzelmann J; Leibensperger H; Froman S; Lines C; Roth T; Michelson D
Biol Psychiatry; 2016 Jan; 79(2):136-48. PubMed ID: 25526970
[TBL] [Abstract][Full Text] [Related]
6. Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting.
Tamura K; Maruyama T; Sakurai S
Ann Thorac Cardiovasc Surg; 2019 Feb; 25(1):26-31. PubMed ID: 30089761
[TBL] [Abstract][Full Text] [Related]
7. Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.
Izuhara M; Izuhara HK; Tsuchie K; Araki T; Ito T; Sato K; Miura S; Otsuki K; Nagahama M; Hayashida M; Hashioka S; Wake R; Kimura T; Tsumoto S; Saito Y; Inagaki M
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33027560
[TBL] [Abstract][Full Text] [Related]
8. Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.
Azimaraghi O; Hammer M; Santer P; Platzbecker K; Althoff FC; Patrocinio M; Grabitz SD; Wongtangman K; Rumyantsev S; Xu X; Schaefer MS; Fuller PM; Subramaniam B; Eikermann M
BMJ Open; 2020 Jul; 10(7):e038474. PubMed ID: 32690536
[TBL] [Abstract][Full Text] [Related]
9. Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men.
Yee KL; McCrea J; Panebianco D; Liu W; Lewis N; Cabalu T; Ramael S; Wrishko RE
Clin Drug Investig; 2018 Jul; 38(7):631-638. PubMed ID: 29705869
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA
J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658
[TBL] [Abstract][Full Text] [Related]
11. Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data.
Herring WJ; Connor KM; Snyder E; Snavely DB; Morin CM; Lines C; Michelson D
Sleep Med; 2019 Apr; 56():219-223. PubMed ID: 30522875
[TBL] [Abstract][Full Text] [Related]
12. Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning.
Bland H; Li X; Mangin E; Yee KL; Lines C; Herring WJ; Gillespie G
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):414-420. PubMed ID: 34181362
[TBL] [Abstract][Full Text] [Related]
13. Effect of Suvorexant vs Placebo on Total Daytime Sleep Hours in Shift Workers: A Randomized Clinical Trial.
Zeitzer JM; Joyce DS; McBean A; Quevedo YL; Hernandez B; Holty JE
JAMA Netw Open; 2020 Jun; 3(6):e206614. PubMed ID: 32484552
[TBL] [Abstract][Full Text] [Related]
14. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
[TBL] [Abstract][Full Text] [Related]
15. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.
Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D
J Clin Sleep Med; 2016 Sep; 12(9):1215-25. PubMed ID: 27397664
[TBL] [Abstract][Full Text] [Related]
16. Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.
Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D
Am J Geriatr Psychiatry; 2017 Jul; 25(7):791-802. PubMed ID: 28427826
[TBL] [Abstract][Full Text] [Related]
17. Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.
Uemura N; McCrea J; Sun H; Donikyan M; Zammit G; Liu R; Louridas B; Marsilio S; Lines C; Troyer MD; Wagner J
J Clin Pharmacol; 2015 Oct; 55(10):1093-100. PubMed ID: 25903940
[TBL] [Abstract][Full Text] [Related]
18. Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.
Sun H; Palcza J; Rosenberg R; Kryger M; Siringhaus T; Rowe J; Lines C; Wagner JA; Troyer MD
Respir Med; 2015 Mar; 109(3):416-26. PubMed ID: 25661282
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
Michelson D; Snyder E; Paradis E; Chengan-Liu M; Snavely DB; Hutzelmann J; Walsh JK; Krystal AD; Benca RM; Cohn M; Lines C; Roth T; Herring WJ
Lancet Neurol; 2014 May; 13(5):461-71. PubMed ID: 24680372
[TBL] [Abstract][Full Text] [Related]
20. Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER-1 study.
Kario K; Yamasaki K; Yagi K; Tsukamoto M; Yamazaki S; Okawara Y; Tomitani N; Kanegae H
J Clin Hypertens (Greenwich); 2019 Jul; 21(7):896-903. PubMed ID: 30874378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
